Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03328663 · ClinicalTrials.gov registry record · NA

Psychological Intervention for Caregivers of Patients Undergoing Stem Cell Transplant

A NA study of Cancer, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03328663: Completed NA study of Cancer, sponsored by Massachusetts General Hospital.

NCT03328663 is a NA study of Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 100 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03328663, a NA study of Cancer, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This research study is evaluating the impact of a psychological intervention on the quality of life and mood of caregivers of patients undergoing stem cell transplant.

Conditions Studied

Interventions

  • OTHER CARE
  • OTHER Standard Transplant Care

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-01-01
Est. Completion 2024-12-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03328663

The ClinicalTrials.gov registry entry for NCT03328663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which CARE is the first listed.

NCT03328663 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03328663 about?

NCT03328663 is a clinical study titled "Psychological Intervention for Caregivers of Patients Undergoing Stem Cell Transplant". This research study is evaluating the impact of a psychological intervention on the quality of life and mood of caregivers of patients undergoing stem cell transplant.

What is the current status of trial NCT03328663?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-01-01. Estimated completion is 2024-12-30.

What conditions does trial NCT03328663 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT03328663?

The interventions under investigation include: CARE (OTHER), Standard Transplant Care (OTHER).

Who is sponsoring clinical trial NCT03328663?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03328663 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.